Picture of ISR Immune System Regulation Holding AB (publ) logo

ISR ISR Immune System Regulation Holding AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Swedish drug maker ISR to launch phase IIa study

Jan 12 (Reuters) - Isr Immune System Regulation Holding Ab 
(Publ)  ISR.ST : 
    * SWEDISH REGULATOR APPROVES Q1 LAUNCH OF PHASE IIA STUDY 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nWkrqSgzL 
Further company coverage:  ISR.ST  
 
 ((terje.solsvik@thomsonreuters.com;))

Recent news on ISR Immune System Regulation Holding AB (publ)

See all news